How have GALT and IVVD total returns compared?

Over the past 5 years, GALT delivered 0.60% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.

Galectin Therapeutics Inc. (GALT) vs Invivyd, Inc. (IVVD)

A side-by-side comparison of Galectin Therapeutics Inc. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GALT

Galectin Therapeutics Inc.

$243M

$3.70HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

IVVD

Invivyd, Inc.

$245M

$0.83HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — GALT vs IVVD

growth of $100 · dividends reinvested · last 5y

GALT +17.7% (+3.3%/yr)IVVD -96.0% (-47.4%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

GALT IVVD

GALT vs IVVD: by the numbers

•IVVD is the larger company ($245M vs $243M market cap).
•Both run net losses; GALT's is the smaller (0.00% vs -183.90% net margin).

Metrics side by side

Valuation

Metric	GALT	IVVD
P/S ratio	N/A	4.19
P/B ratio	N/A	1.35

Profitability

Metric	GALT	IVVD
Gross margin	0.00%	91.35%
Operating margin	0.00%	-103.99%
Net margin	0.00%	-183.90%
ROE	N/A	-59.27%
ROIC	-1718.59%	-59.90%

Growth (annualized)

Metric	GALT	IVVD
Total return CAGR (5Y)	0.60%	-51.69%

Frequently asked

How have GALT and IVVD total returns compared?: Over the past 5 years, GALT delivered 0.60% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GALT analysis Full IVVD analysis Interactive comparison tool

Dig into the metrics

Galectin Therapeutics ROE Invivyd ROE Galectin Therapeutics operating margin Invivyd operating margin Galectin Therapeutics revenue growth Invivyd revenue growth Galectin Therapeutics free cash flow Invivyd free cash flow

Galectin Therapeutics & Invivyd appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.